A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study-Reference-Cited by-同舟云学术

A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study

Published:2022-09 Issue: Volume:30 Page:390-394
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Pascale Renato,Maccaro Angelo^ORCID,Mikus Elisa,Baldassarre Maurizio,Tazza Beatrice,Esposito Fabio,Rinaldi Matteo,Tenti Elena,Ambretti Simone,Albertini Alberto^ORCID,Viale Pierluigi,Giannella Maddalena,Bartoletti Michele

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference26 articles.

1. Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery;Lu;Eur J Cardiothorac Surg,2003

2. Risk factors for sternal wound infection after open heart operations vary according to type of operation;Meszaros;Ann Thorac Surg,2016

3. Mediastinitis and long-term survival after coronary artery bypass graft surgery;Braxton;Ann Thorac Surg,2000

4. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 update on outcomes and quality;D’Agostino;Ann Thorac Surg,2018

5. Sternal wound infections in patients after coronary artery bypass grafting using bilateral skeletonized internal mammary arteries;Sofer;Ann Surg,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview;Global and Regional Health Technology Assessment;2024-07-29

2. In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry;Infection;2024-02-07

3. EFFECT OF INTEGRATED HOLISTIC NURSING MODEL ON THE SUCCESS RATE, COMPLICATIONS AND COOPERATION OF ATHLETHIC PATIENTS UNDERGOING CARDIAC SURGERY;REV INT MED CIENC AC;2022

4. Update on the Management of Surgical Site Infections;Antibiotics;2022-11-11